- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Embla Medical hf (EMBLA)
Embla Medical hf stock price live, this page displays CSE EMBLA stock exchange data. View the EMBLA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Embla Medical hf real time stock price chart below.
What Is the Embla Medical hf Stock Price Today?
The Embla Medical hf stock price today is 29.80.
What Is the Stock Symbol for Embla Medical hf?
The stock symbol for Embla Medical hf is "EMBLA."
What Stock Exchange Does Embla Medical hf Trade On?
Embla Medical hf is listed and trades on the Copenhagen stock exchange.
Is Embla Medical hf a Good Stock to Buy?
Determining whether Embla Medical hf—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EMBLA quote. (ISIN: IS0000000040)
What Is the Embla Medical hf Stock Price Today?
The Embla Medical hf stock price today is 29.80.
What Is the Stock Symbol for Embla Medical hf?
The stock symbol for Embla Medical hf is "EMBLA."
What Stock Exchange Does Embla Medical hf Trade On?
Embla Medical hf is listed and trades on the Copenhagen stock exchange.
Is Embla Medical hf a Good Stock to Buy?
Determining whether Embla Medical hf—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EMBLA quote. (ISIN: IS0000000040)
Copenhagen
Currency in DKK
29.80
-0.40(-1.32%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.30
30.20
52 wk Range
25.01
37.90
EMBLA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.3030.20
52 wk Range
25.0137.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EMBLA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
37.40
Upside
+25.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts predict the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Embla Medical hf Company Profile
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides osteoarthritis solutions that are designed to reduce pain and improve mobility for people living with osteoarthritis; and injury solutions for people recovering from fractures, ligament injuries, or need post-operative treatment. This segment also offers Unloader One, a range knee braces that relieve pain from knee osteoarthritis; and Unloader Hip, which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip. The Patient Care segment provides prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. The company serves orthopedic and prosthetic clinics, hospitals, and surgery centers. It sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024. Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.
Embla Medical hf Earnings Call Summary for Q3/2025
- Q3 revenue reached $237M, up 11% YoY, with 7% organic growth; EPS beat expectations, driving stock up 3.17% to $32.50
- Prosthetics and orthotics segments saw 13% organic growth, boosted by ArtiseiQ and ICON launches; APAC and EMEA sales increased
- Full-year guidance maintained at 5-6% organic growth with 20-21% EBITDA margin; H2 expected to be stronger
- Potential U.S. trade restrictions could impact future earnings; company exploring U.S. production options to mitigate tariffs
- CEO confident in long-term strategy despite challenges in bracing segment; aims to return to market growth rates by 2026
Last Updated: 2025-10-21, 04:32 a/m
Read Full TranscriptCompare EMBLA to Peers and Sector
Metrics to compare | EMBLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEMBLAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.5x | 15.4x | −0.6x | |
PEG Ratio | 1.11 | 0.06 | 0.00 | |
Price/Book | 2.3x | 2.4x | 2.6x | |
Price / LTM Sales | 2.2x | 1.4x | 3.3x | |
Upside (Analyst Target) | 25.2% | 277.9% | 45.0% | |
Fair Value Upside | Unlock | 14.8% | 6.1% | Unlock |
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 37.40
(+25.50% Upside)
Earnings
Latest Release
Feb 03, 2026
EPS / Forecast
0.058 / 0.0573
Revenue / Forecast
257.00M / 254.43M
People Also Watch
FAQ
What Is the Embla Medical hf (EMBLA) Stock Price Today?
The Embla Medical hf stock price today is 29.80
What Stock Exchange Does Embla Medical hf Trade On?
Embla Medical hf is listed and trades on the Copenhagen Stock Exchange.
What Is the Stock Symbol for Embla Medical hf?
The stock symbol for Embla Medical hf is "EMBLA."
What Is the Embla Medical hf Market Cap?
As of today, Embla Medical hf market cap is 12.74B.
What Is Embla Medical hf's Earnings Per Share (TTM)?
The Embla Medical hf EPS (TTM) is 0.20.
When Is the Next Embla Medical hf Earnings Date?
Embla Medical hf will release its next earnings report on Apr 28, 2026.
From a Technical Analysis Perspective, Is EMBLA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Embla Medical hf Stock Split?
Embla Medical hf has split 0 times.
How Many Employees Does Embla Medical hf Have?
Embla Medical hf has 4195 employees.
What is the current trading status of Embla Medical hf (EMBLA)?
As of Feb 24, 2026, Embla Medical hf (EMBLA) is trading at a price of 29.80, with a previous close of 30.20. The stock has fluctuated within a day range of 29.30 to 30.20, while its 52-week range spans from 25.01 to 37.90.
What Is Embla Medical hf (EMBLA) Price Target According to Analysts?
The average 12-month price target for Embla Medical hf is DKK37.40, with a high estimate of DKK40 and a low estimate of DKK34. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +25.50% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.